Results 71 to 80 of about 6,390 (108)

Effective high-dose methotrexate toxicity reversal using fixed-dose glucarpidase in obese patients: a case series. [PDF]

J Med Case Rep
Grofvert J, Van Rossum B, Pettijohn E, Mobayed M, Stonerock D.   +4 more
europepmc   +1 more source

Multimodality imaging in the detection and management of coronary and peripheral arterial disease in patients with cancer receiving cardiotoxic antineoplastic treatments: A clinical consensus statement of the ESC Council of Cardio-Oncology and the European Association of Cardiovascular Imaging (EACVI) of the ESC. [PDF]

Eur Heart J Cardiovasc Imaging
Novo G, Lopez-Fernandez T, Delgado V, Lancellotti P, Almeida AG, Bergler-Klein J, Celutkiene J, Dweck MR, Guglielmo M, Gulati G, Mirsadraee S, Nazir MS, Lyon AR, Stankovic I.   +13 more
europepmc   +1 more source

Economic and organizational impact of oral versus intravenous and subcutaneous administration of hypomethylating agents in patients with acute myeloid leukemia not eligible for intensive chemotherapy in Spain. [PDF]

PLoS One
Lloret Avellá M, Carmo M, Paladio Duran N, Blancher Parcerisa P.   +3 more
europepmc   +1 more source

SLC15A3-mediated dipeptide metabolism confers antimetabolite resistance in lymphoma via mTORC1 activation. [PDF]

J Clin Invest
Yang H, Zingaro VA, Boardman K, Noronha A, Guney E, Xue L, Hoigebazar S, Liu I, Miglani S, Chen S, Vu H, Wen KW, Nguyen HG, Goodarzi H, DeBerardinis RJ, Ruggero D.   +15 more
europepmc   +1 more source

Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer. [PDF]

J Clin Oncol
Ikeda M, Nakachi K, Konishi M, Kajikawa R, Katayama H, Sano Y, Sugiura T, Satoi S, Murakawa M, Tomokuni A, Nara S, Takahashi Y, Okada KI, Hama N, Kamei K, Kamata K, Natsume S, Okusaka T, Furuse J, Ueno M.   +19 more
europepmc   +1 more source

Critical analysis of withdrawn drug applications in marketing authorization procedures of the European Medicines Agency (EMA) 2006-2024. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Hitsch F, Seifert R.
europepmc   +1 more source

Arrhythmias, conduction disorders and sudden cardiac death in cancer patients and survivors: expert opinion of the working groups on cardio-oncology and on electrophysiology of the hellenic cardiac society. [PDF]

Cardiooncology
Keramida K, Kariki O, Angelopoulou E, Kalafatis I, Lafaras C, Letsas KP, Michalopoulou H, Saplaouras A, Tampakis K, Tsekoura D, Andrikopoulos G.   +10 more
europepmc   +1 more source

Ultra-low Concentrations of Cisplatinum Down to the IC₁₀ in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>. [PDF]

In Vivo
Asano Y, Han Q, Li S, Kang BM, Kim JS, Miyashi Y, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Morinaga S, Tsuchiya H, Demura S, Hoffman RM.   +16 more
europepmc   +1 more source

A rare variant in DPYD c.812delT causes severe adverse events of S-1 in a patient with tongue cancer. [PDF]

Cancer Chemother Pharmacol
Ishimura H, Suehiro A, Hira D, Hishinuma E, Kato M, Maekawa M, Yasuda T, Katsube Y, Katada Y, Imayoshi N, Shigetsura Y, Nakagawa S, Tsuda M, Hiratsuka M, Terada T.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The efficacy and toxicity of antineoplastic antimetabolites: Role of gut microbiota

Toxicology, 2021
The incidence and mortality of cancer are rapidly growing all over the world. Nowadays, antineoplastic antimetabolites still play a key role in the chemotherapy of cancer. However, the interindividual variations in the efficacy and toxicity of antineoplastic antimetabolites are nonnegligible challenges to their clinical applications.
Xinyi Huang, Lulu Chen, Zhenyu Li, Binjie Zheng, Na Liu, Qing Fang, Jinsheng Jiang, Tai Rao, Dongsheng Ouyang   +8 more
openaire   +2 more sources